Radiotherapy and "new" drugs-new side effects?

Episode von Medizin - Open Access LMU - Teil 18/22 von Ludwig-Maximilians-Universität München · 1. Januar 2011

Background and purpose: Targeted drugs have augmented the cancer treatment armamentarium. Based on the molecular specificity, it was initially believed that these drugs had significantly less side effects. However, currently it is accepted that all of these agents have their specific side effects. Based on the given multimodal approach, special emphasis has to be placed on putative interactions of conventional cytostatic drugs, targeted agents and other modalities. The interaction of targeted drugs with radiation harbours special risks, since the awareness for interactions and even synergistic toxicities is lacking. At present, only limited is data available regarding combinations of targeted drugs and radiotherapy. This review gives an overview on the current knowledge on such combined treatments. Materials and methods: Using the following MESH headings and combinations of these terms pubmed database was searched: Radiotherapy AND cetuximab/trastuzumab/panitumumab/nimotuzumab, bevacizumab, sunitinib/sorafenib/lapatinib/gefitinib/erlotinib/sirolimus, thalidomide/lenalidomide as well as erythropoietin. For citation crosscheck the ISI web of science database was used employing the same search terms. Results: Several classes of targeted substances may be distinguished: Small molecules including kinase inhibitors and specific inhibitors, antibodies, and anti-angiogenic agents. Combination of these agents with radiotherapy may lead to specific toxicities or negatively influence the efficacy of RT. Though there is only little information on the interaction of molecular targeted radiation and radiotherapy in clinical settings, several critical incidents are reported. Conclusions: The addition of molecular targeted drugs to conventional radiotherapy outside of approved regimens or clinical trials warrants a careful consideration especially when used in conjunction in hypo-fractionated regimens. Clinical trials are urgently needed in order to address the open question in regard to efficacy, early and late toxicity.

Weitere Episoden von „Medizin - Open Access LMU - Teil 18/22“

• Carotid Atherosclerotic Markers in CADASIL 1. Januar 2011
• CDKN2BAS is associated with periodontitis in different European populations and is activated by bacterial infection 1. Januar 2011
• Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-beta(38/40/42) in Frontotemporal Dementias and Primary Progressive Aphasias 1. Januar 2011
• Comparative Chromosome Maps of Neotropical Rodents Necromys lasiurus and Thaptomys nigrita (Cricetidae) Established by ZOO-FISH 1. Januar 2011
• Contribution of Matrix Metalloproteinase-9 to Cerebral Edema and Functional Outcome following Experimental Subarachnoid Hemorrhage 1. Januar 2011
• Critical Micronutrients in Pregnancy, Lactation, and Infancy: Considerations on Vitamin D, Folic Acid, and Iron, and Priorities for Future Research 1. Januar 2011
• Einsatz der Matrix-Assisted Laser Desorption/ionisation-Time of Flight Massenspektrometrie (MALDI-TOF MS) in der mikrobiologischen Routinediagnostik 1. Januar 2011
• Endometrial cancer - reduce to the minimum. Anew paradigm for adjuvant treatments? 1. Januar 2011
• Evaluation of a commercially available rapid urinary porphobilinogen test 1. Januar 2011
• First steps towards a fast-neutron therapy planning program 1. Januar 2011
• Harmonization of growth hormone measurements with different immunoassays by data adjustment 1. Januar 2011
• Hemotrophic Mycoplasmas Induce Programmed Cell Death in Red Blood Cells 1. Januar 2011
• High (but Not Low) Urinary Iodine Excretion Is Predicted by Iodine Excretion Levels from Five Years Ago 1. Januar 2011
• Holocentric Chromosomes of Luzula elegans Are Characterized by a Longitudinal Centromere Groove, Chromosome Bending, and a Terminal Nucleolus Organizer Region 1. Januar 2011
• Age determination of vessel wall hematoma in spontaneous cervical artery dissection: A multi-sequence 3T Cardiovascular Magnetic resonance study 1. Januar 2011

Alle Episoden von Medizin - Open Access LMU - Teil 18/22 · Mehr Bildung-Podcasts